Can fatty liver cause burning sensation? This is a common concern amongst patients diagnosed with hepatic steatosis. Fatty liver disease affects approximately one in three UK adults, yet many remain unaware of their condition until routine testing reveals it. Whilst fatty liver itself rarely produces burning sensations—as the liver lacks pain receptors—patients often experience coexisting gastrointestinal conditions that do cause such discomfort. Understanding the true relationship between fatty liver and burning symptoms is essential for appropriate diagnosis and management. This article explores the evidence, examines alternative causes of burning sensations, and provides guidance on when to seek medical advice.

Understanding Fatty Liver Disease and Its Symptoms

Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates in liver cells. In the UK, non-alcoholic fatty liver disease (NAFLD) affects approximately one in three adults and is increasingly recognised as a significant public health concern. The condition exists in two main forms: non-alcoholic fatty liver disease (NAFLD), which develops in people who drink little or no alcohol, and alcohol-related liver disease (ARLD), in which alcohol-related fatty liver is an early stage resulting from excessive alcohol consumption.

The majority of individuals with fatty liver disease experience no symptoms in the early stages, which is why it is often discovered incidentally during routine blood tests or imaging performed for other reasons. When symptoms do occur, they tend to be vague and non-specific. Patients may report persistent fatigue, a general sense of unwellness, or discomfort in the upper right abdomen where the liver is located. Some describe a sensation of fullness or heaviness in this area, particularly after eating.

As the condition progresses to more advanced stages—such as non-alcoholic steatohepatitis (NASH) or cirrhosis—symptoms may become more pronounced. These can include:

• Persistent abdominal discomfort or pain

• Unexplained weight loss

• Weakness and loss of appetite

• Jaundice (yellowing of the skin and eyes)

• Swelling in the legs and abdomen

It is important to understand that fatty liver disease exists on a spectrum. Simple steatosis (fat accumulation alone) may be reversible with lifestyle changes, whilst NASH involves inflammation and liver cell damage that can progress to fibrosis and cirrhosis if left unmanaged. NAFLD is also associated with increased cardiovascular risk, and cardiovascular disease is a leading cause of morbidity and mortality in affected individuals. The NHS and NICE (NG49) recommend regular monitoring for individuals at risk, including those with obesity, type 2 diabetes, or metabolic syndrome.

Can Fatty Liver Cause Burning Sensation?

The relationship between fatty liver disease and burning sensations is not straightforward. Burning pain is not a typical or recognised symptom of fatty liver disease, and evidence for a direct causal link is limited. The liver itself has no pain receptors within its tissue, which means that fat accumulation alone does not typically produce painful or burning sensations. However, patients with fatty liver disease may experience discomfort through indirect mechanisms.

When the liver becomes enlarged due to fat accumulation—a condition called hepatomegaly—it can stretch the liver capsule (Glisson's capsule), which does contain nerve endings. This stretching may produce a dull, aching sensation in the upper right quadrant of the abdomen, though patients rarely describe this as a burning feeling. The discomfort is more commonly characterised as heaviness, fullness, or a vague ache that may worsen after meals.

Some patients with fatty liver disease report sensations they interpret as burning, but these are more likely attributable to associated conditions rather than the fatty liver itself. Many individuals with NAFLD have metabolic syndrome, which includes obesity, insulin resistance, and dyslipidaemia. These patients are also at increased risk of gastro-oesophageal reflux disease (GORD), peptic ulcer disease, and gastritis—all of which commonly cause burning sensations in the upper abdomen and chest.

Furthermore, the lifestyle factors that contribute to fatty liver disease, such as poor diet and obesity, also predispose individuals to digestive disorders that manifest with burning symptoms. It is therefore essential to consider that whilst fatty liver and burning sensations may coexist in the same patient, the burning is typically caused by a separate gastrointestinal condition rather than the liver pathology itself. A thorough clinical assessment is necessary to identify the true source of symptoms.

Other Causes of Burning Sensation in the Upper Abdomen

When patients experience burning sensations in the upper abdomen, several common gastrointestinal conditions should be considered as more likely culprits than fatty liver disease itself. Gastro-oesophageal reflux disease (GORD) is a common cause, occurring when stomach acid flows back into the oesophagus, causing a characteristic burning sensation (heartburn) in the chest and upper abdomen, often worsening after meals or when lying down.

Peptic ulcer disease, involving ulceration of the stomach lining (gastric ulcer) or the first part of the small intestine (duodenal ulcer), commonly presents with burning epigastric pain. This discomfort may be relieved or exacerbated by eating, depending on the ulcer location. Risk factors include Helicobacter pylori infection, regular use of non-steroidal anti-inflammatory drugs (NSAIDs), and smoking. NICE guidelines (CG184) recommend testing for H. pylori in patients with dyspepsia and treating when positive.

Gastritis, or inflammation of the stomach lining, produces similar burning symptoms and shares many risk factors with peptic ulcer disease. Other potential causes include:

• Functional dyspepsia: persistent upper abdominal discomfort without identifiable structural cause

• Biliary colic: caused by gallstones, producing episodic right upper quadrant pain

• Pancreatitis: inflammation of the pancreas, causing severe epigastric pain radiating to the back

• Medication side effects: particularly NSAIDs, aspirin, and certain antibiotics

Certain dietary triggers can exacerbate burning sensations, including spicy foods, caffeine, alcohol, and high-fat meals. Stress and anxiety may also contribute to functional gastrointestinal symptoms. Given the overlap in symptoms between these various conditions, accurate diagnosis often requires a combination of clinical history, physical examination, and appropriate investigations such as endoscopy or abdominal ultrasound.

If you experience symptoms that you think may be side effects of a medicine, you can report them via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or by searching for 'Yellow Card' in the Google Play or Apple App Store.

When to Seek Medical Advice for Liver-Related Symptoms

Whilst fatty liver disease is often asymptomatic and discovered incidentally, certain symptoms warrant prompt medical evaluation. Patients should contact their GP if they experience persistent upper abdominal discomfort, unexplained fatigue lasting several weeks, or any symptoms suggestive of liver dysfunction. Early assessment allows for timely diagnosis and intervention before progression to more serious liver disease.

Urgent medical attention is required if you develop any of the following warning signs, which may indicate advanced liver disease or complications:

• Jaundice: yellowing of the skin or whites of the eyes

• Dark urine and pale stools

• Persistent vomiting, particularly if blood-stained (haematemesis)

• Severe abdominal pain that is sudden or rapidly worsening

• Abdominal swelling (ascites) or swelling of the ankles and legs

• Confusion or altered mental state (hepatic encephalopathy)

• Easy bruising or bleeding

For burning sensations specifically, seek medical advice if the discomfort is severe, persistent, or accompanied by alarm features. NICE guidance (NG12) recommends urgent referral (within two weeks) for suspected upper gastrointestinal cancer if you have:

• Dysphagia (difficulty swallowing) at any age

• Age 55 or over with weight loss and upper abdominal pain, reflux, or dyspepsia

• Haematemesis (vomiting blood)

Patients with known risk factors for fatty liver disease—including obesity (BMI ≥30), type 2 diabetes, high cholesterol, or metabolic syndrome—should discuss screening with their GP even in the absence of symptoms. It is important to note that liver blood tests (LFTs) can be normal in NAFLD, so normal results do not exclude the condition. NICE (NG49) recommends primary care risk stratification using tools such as the FIB-4 or NAFLD fibrosis score to assess the risk of advanced liver fibrosis. If indicated, an Enhanced Liver Fibrosis (ELF) blood test may be arranged, and patients with results suggesting advanced fibrosis should be referred to hepatology. Imaging such as ultrasound or transient elastography can assess liver fat and stiffness. Early detection enables lifestyle modifications and medical management that can prevent disease progression and improve long-term outcomes.

Managing Fatty Liver Disease in the UK

Management of fatty liver disease in the UK follows NICE guidelines (NG49) and focuses primarily on addressing underlying risk factors through lifestyle modification. For most patients with simple steatosis or early NASH, no specific medication is required, and the condition can often be improved through sustained lifestyle changes. The cornerstone of treatment involves weight reduction, dietary modification, and increased physical activity.

Weight loss is the most effective intervention for NAFLD. Evidence supports a target of 7–10% body weight reduction, which has been shown to improve liver fat content, inflammation, and even fibrosis. This should be achieved gradually through a combination of reduced calorie intake and increased physical activity. Crash diets are not recommended, as rapid weight loss can paradoxically worsen liver inflammation. The NHS provides access to weight management services, including dietitian support and structured programmes, which patients can access through GP referral. For individuals meeting specific criteria, bariatric surgery may be considered in line with NICE obesity guidance.

Dietary recommendations include:

• Reducing intake of refined carbohydrates and added sugars

• Limiting saturated fats and avoiding trans fats

• Increasing consumption of fruits, vegetables, and whole grains

• Following a Mediterranean-style diet, which has evidence for liver health benefits

• Avoiding or strictly limiting alcohol consumption (abstinence is recommended in ARLD and often advised in NAFLD)

Physical activity should include at least 150 minutes of moderate-intensity exercise weekly, as recommended by the UK Chief Medical Officers' Physical Activity Guidelines. Exercise improves insulin sensitivity and reduces liver fat independent of weight loss.

For patients with alcohol-related liver disease, complete alcohol abstinence is essential. The NHS offers alcohol support services, and GPs can refer patients to specialist addiction services when needed.

Management of associated cardiovascular risk factors is crucial, as cardiovascular disease is a leading cause of death in people with NAFLD. This includes optimising control of blood pressure, blood glucose, and lipids. Statins are safe and indicated for dyslipidaemia in NAFLD when clinically appropriate and should not be withheld due to concerns about liver disease. Patients with diabetes may benefit from medications such as metformin or newer agents that also support weight loss.

Patients with advanced fibrosis or cirrhosis require specialist hepatology input and regular monitoring for complications including hepatocellular carcinoma. Whilst there are currently no licensed medications specifically for NAFLD in the UK, research is ongoing. Regular follow-up with blood tests, fibrosis assessment, and imaging helps monitor disease progression and treatment response.

Frequently Asked Questions